Open | $5.240 |
Close | $5.140 |
Volume / Avg. | 3.160M / 9.433M |
Day Range | 5.100 - 5.370 |
52 Wk Range | 3.532 - 11.360 |
Market Cap | $713.761M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 45.66% |
Days to Cover | 8.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Fusion Pharmaceuticals (NASDAQ:FUSN), Pharming (NASDAQ:PHAR) and Fate Therapeutics (NASDAQ:FATE).
The latest price target for Novavax (NASDAQ: NVAX) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 19.00 expecting NVAX to rise to within 12 months (a possible 272.55% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $5.1 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.